Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: A systematic review and meta-analysis

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 2, 2015, Pages 396-404

  Machaira, Maria ^a   Papaevangelou, Vassiliki ^b   Vouloumanou, Evridiki K ^c   Tansarli, Giannoula S ^c   Falagas, Matthew E ^c,d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b 'Attikon' General University Hospital   (United States)

^c ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HBV; Hepatitis B virus; Immunization

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; HEPATITIS B HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN;

ARTICLE; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; FEMALE; FULMINANT HEPATIC FAILURE; HEPATITIS B; HUMAN; IMMUNIZATION; MEDLINE; META ANALYSIS; MONOTHERAPY; NEWBORN; SCOPUS; SYSTEMATIC REVIEW; BLOOD; IMMUNOLOGY; INFANT; OUTCOME ASSESSMENT; PREVENTION AND CONTROL; RISK; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VERTICAL TRANSMISSION;

HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ODDS RATIO; PATIENT OUTCOME ASSESSMENT;

EID: 84922472057     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku404     Document Type: Article

References (35)

1. WHO. http://www.who.int/mediacentre/factsheets/fs204/en.
2. Yao JL. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut 1996; 38 Suppl 2: S37-8.
3. Lee C, Gong Y, Brok J et al. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006; 332: 328-36.
4. Akhter S, Talukder MQ, Bhuiyan N et al. Hepatitis B virus infection in pregnant mothers and its transmission to infants. Indian J Pediatr 1992; 59: 411-5.
5. Beasley RP, Trepo C, Stevens CE et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105: 94-8.
6. Okada K, Kamiyama I, Inomata M et al. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. New Engl J Med 1976; 294: 746-9.
7. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med 2007; 12: 160-7.
8. Chen HL, Chang CJ, Kong MS et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 2004; 39: 58-63.
9. Sterneck M, Kalinina T, Otto S et al. Neonatal fulminant hepatitis B: structural and functional analysis of complete hepatitis B virus genomes from mother and infant. J Infect Dis 1998; 177: 1378-81.
10. Poovorawan Y, Theamboonlers A, Vimolket Tet al. Impact of hepatitis B immunisation as part of the EPI. Vaccine 2000; 19: 943-9.
11. Boxall EH, J AS, El-Shuhkri N et al. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis 2004; 190: 1264-9.
12. Yang YJ, Liu CC, Chen TJ et al. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Pediatr Infect Dis J 2003; 22: 584-8.
13. Liu ZH, Men K, Xu D. [A follow-up study on correlated factors for intrauterine infection of hepatitis B virus]. Zhonghua Yu Fang Yi Xue Za Zhi 1997; 31: 263-5.
14. Wang Y, Yan YP, Zhang Y et al. [A follow-up study on the efficacy of hepatitis B immunoglobulin combining hepatitis B vaccine in infants born to HBsAg positive mothers]. Zhonghua Liu Xing Bing Xue Za Zhi 2007; 28: 550-4.
15. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996; 12: 195-208.
16. Moher D, Pham B, Jones A et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-13.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
18. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
19. Pande C, Sarin SK, Patra S et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat 2013; 20: 801-10.
20. Wen WH, Chang MH, Zhao LL et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013; 59: 24-30.
21. Chen HL, Lin LH, Hu FC et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012; 142: 773-81 e2.
22. Xu ZY, Duan SC, Margolis HS et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B. J Infect Dis 1995; 171: 54-60.
23. Sehgal A, Sehgal R, Gupta I et al. Use of hepatitis B vaccine alone or in combination with hepatitis B immunoglobulin for immunoprophylaxis of perinatal hepatitis B infection. J Trop Pediatr 1992; 38: 247-51.
24. Wheeley SM, Jackson PT, Boxall EH et al. Prevention of perinatal transmission of hepatitis B virus (HBV): a comparison of two prophylactic schedules. J Med Virol 1991; 35: 212-5.
25. Esteban JI, Genesca J, Esteban R et al. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area. J Med Virol 1986; 18: 381-91.
26. Sun TT, Chu YR, Ni ZQ et al. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine. J Cell Physiol Suppl 1986; 4: 83-90.
27. Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. Vaccine 2013; 31: 2506-16.
28. Papaevangelou V. Perinatal HBV viremia in newborns of HBsAg+ mothers is a transient phenomenon that does not necessarily imply HBV infection transmission. J Clin Virol 2012; 54: 202.
29. Grammatikos AP, Mantadakis E, Falagas ME. Meta-analyses on pediatric infections and vaccines. Infect Dis Clin N Am 2009; 23: 431-57.
30. Makris MC, Polyzos KA, Mavros MN et al. Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf 2012; 35: 1-14.
31. Fawaz KA, Grady GF, Kaplan MM et al. Repetitive maternal-fetal transmission of fatal hepatitis B. New Engl J Med 1975; 293: 1357-9.
32. Friedt M, Gerner P, Lausch E et al. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 1999; 29: 1252-8.
33. von Weizsacker F, Pult I, Geiss K et al. Selective transmission of variant genomes from mother to infant in neonatal fulminant hepatitis B. Hepatology 1995; 21: 8-13.
34. Chen SC, Toy M, Yeh JM et al. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment. Pediatrics 2013; 131: e1135-43.
35. Su H, Zhang Y, Xu D et al. Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China. PLoS One 2013; 8: e70768.